Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Interaction of human serum albumin with anticancer agents In Vitro
Takao Ohnuma
, T. Ohnuma
, S. Kavy
, S. Bhardwaj
, J. F. Holland
Icahn School of Medicine at Mount Sinai
Research output
:
Contribution to journal
›
Article
›
peer-review
42
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Interaction of human serum albumin with anticancer agents In Vitro'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Human Serum Albumin
100%
Anticancer Agents
100%
Biological Activity
62%
Daunorubicin
12%
Biological Effects
12%
Clinical Efficacy
12%
Adriamycin
12%
Vinblastine
12%
Mitomycin C
12%
Cytosine Arabinoside
12%
Pharmacology
12%
Bleomycin
12%
Human Leukemia Cell Line
12%
MOLT-3
12%
Fluorouracil
12%
Cis-diamminedichloroplatinum
12%
Actinomycin D
12%
Nitrogen mustard
12%
Type 1 Agents
12%
Albumin-drug Interaction
12%
Neocarzinostatin
12%
Pharmacology, Toxicology and Pharmaceutical Science
Human Serum Albumin
100%
Anticancer Drug
100%
Biological Activity
62%
Daunorubicin
12%
Cytarabine
12%
Doxorubicin
12%
Cisplatin
12%
Drug Interaction
12%
Leukemia
12%
Vincristine
12%
Vinblastine
12%
Fluorouracil
12%
Bleomycin
12%
Mitomycin
12%
Dactinomycin
12%
Nitrogen Mustard
12%
Zinostatin
12%